Royalty Pharma Other Operating Income or Expenses 2019-2025 | RPRX
Royalty Pharma other operating income or expenses for the twelve months ending March 31, 2025 were $-0.022B, a 97.88% decline year-over-year.
- Royalty Pharma annual other operating income or expenses for 2024 were $-0.732B, a 30.64% increase from 2023.
- Royalty Pharma annual other operating income or expenses for 2023 were $-0.561B, a 63.12% decline from 2022.
- Royalty Pharma annual other operating income or expenses for 2022 were $-1.52B, a 235.67% increase from 2021.